ARCHIVES

FDA to Require Data On saline Breast, Silcone Testicular Implants

This article is from The Cancer Letter archive.

Vol. 19 No. 05 | January 29, 1993

Download PDF Visit The Full Archive

Related Articles

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

In Brief: President OK’s Mammography Standard Publication, CDC State Grants Increase

January 7, 1994